» Articles » PMID: 20382118

Foxa2 (HNF-3beta) Regulates Expression of Hepatotrophic Factor ALR in Liver Cells

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2010 Apr 13
PMID 20382118
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Liver regeneration is a multistep and well-orchestrated process which is initiated by injuries such as tissue loss, infectious or toxic insults. Augmenter of liver regeneration (ALR) is a hepatotrophic growth factor which has been shown to stimulate hepatic regeneration after partial hepatectomy and therefore seems to be regulated during the regenerative process in the liver. Our aim was to analyze how ALR is regulated in hepatic tissues and which transcription factors might regulate its tissue-specific expression. Promoter studies of ALR (-733/+527 bp) revealed potential regulatory elements for various transcription factors like Foxa2, IL-6 RE-BP and C/EBPbeta. Analysis of the promoter activity by performing luciferase assays revealed that co-transfection with Foxa2 significantly induced the activity of ALR promoter in HepG2 cells. EMSA and Supershift analysis using anti-Foxa2 antibody confirmed the specific binding of Foxa2 to ALR promoter and this binding was inducible when the cells were simultaneously stimulated with IL-6. The increased binding after activation with IL-6 and/or Foxa2 was confirmed by elevated ALR protein levels using Western blot technique. In addition, we could not detect any binding of C/EBPbeta and IL-6 RE-BP to the promoter of ALR. In conclusion, these results indicate that ALR is regulated by Foxa2, and this regulation may be amplified by IL-6.

Citing Articles

Interleukin-1ß Attenuates Expression of Augmenter of Liver Regeneration (ALR) by Regulating HNF4α Independent of c-Jun.

Nimphy J, Ibrahim S, Dayoub R, Kubitza M, Melter M, Weiss T Int J Mol Sci. 2023; 24(9).

PMID: 37175814 PMC: 10179097. DOI: 10.3390/ijms24098107.


The role of FOXA family transcription factors in glucolipid metabolism and NAFLD.

Yu C, Li X, Zhao Y, Hu Y Front Endocrinol (Lausanne). 2023; 14:1081500.

PMID: 36798663 PMC: 9927216. DOI: 10.3389/fendo.2023.1081500.


The protective roles of augmenter of liver regeneration in hepatocytes in the non-alcoholic fatty liver disease.

Dong Y, Zhang Y, Feng Y, An W Front Pharmacol. 2022; 13:928606.

PMID: 36304168 PMC: 9592723. DOI: 10.3389/fphar.2022.928606.


Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.

Weiss T, Lupke M, Ibrahim S, Buechler C, Lorenz J, Ruemmele P PLoS One. 2017; 12(9):e0184282.

PMID: 28877220 PMC: 5587239. DOI: 10.1371/journal.pone.0184282.


Role of Nrf2 in chronic liver disease.

Tang W, Jiang Y, Ponnusamy M, Diallo M World J Gastroenterol. 2014; 20(36):13079-87.

PMID: 25278702 PMC: 4177487. DOI: 10.3748/wjg.v20.i36.13079.